N.J. Admin. Code § 13:45A-35.3

Current through Register Vol. 56, No. 21, November 4, 2024

Section 13:45A-35.3 - Pharmacy reporting requirements; electronic format

(a) A pharmacy filling a prescription for a Schedule II, III, IV, or V controlled dangerous substance, for human growth hormone, as defined in N.J.A.C. 13:45A-35.1, or for gabapentin, in an outpatient setting, shall collect and electronically transmit to the Division's PMP vendor on a daily basis information for each prescription, as specified in the New Jersey PMP Data Collection Manual.

1. For purposes of this section, in accordance with N.J.S.A. 45:1-45 and as specified in the Data Collection Manual, the following information shall be collected and transmitted to the Division:

i. The surname, first name, and date of birth of the patient for whom the medication is intended;

ii. The street address and telephone number of the patient;

iii. The date that the medication is dispensed;

iv. The number or designation identifying the prescription and the National Drug Code of the drug dispensed;

v. The pharmacy permit number of the dispensing pharmacy;

vi. The prescribing practitioner's name and Drug Enforcement Administration registration number;

vii. The name, strength, and quantity of the drug dispensed, the number of refills ordered, and whether the drug was dispensed as a refill or a new prescription;

viii. The date that the prescription was issued by the practitioner;

ix. The source of payment for the drug dispensed;

x. Identifying information for any individual, other than the patient for whom the prescription was written, who picks up the prescription, if the pharmacist has a reasonable belief that the person picking up the prescription may be seeking a controlled dangerous substance, in whole or in part, for any reason other than delivering the substance to the patient for the treatment of an existing medical condition.

(1) For purposes of this subparagraph, "identifying information" includes the individual's first and last name, relationship to the patient, and, if available, the type of, and identification number on, a state or Federal government identification; and

xi. Such other information, not inconsistent with Federal law, regulation, or funding eligibility requirements, as the Director determines necessary and that is set forth in the Data Collection Manual.

N.J. Admin. Code § 13:45A-35.3

Adopted by 48 N.J.R. 2374(a), effective 11/7/2016

Amended by 50 N.J.R. 1219(a), effective 5/7/2018

Amended by 51 N.J.R. 624(a), effective 5/6/2019

Administrative Change, 51 N.J.R. 897(b).